Clinical and Microbiological Features of HIV-Associated Tuberculous Meningitis in Vietnamese Adults

被引:71
作者
Torok, M. Estee [1 ,4 ]
Chau, Tran Thi Hong [2 ]
Mai, Pham Phuong [2 ]
Phong, Nguyen Duy [2 ]
Dung, Nguyen Thi [2 ]
Van Chuong, Ly [2 ]
Lee, Sue J. [3 ]
Caws, M. [1 ,4 ]
de Jong, Menno D. [1 ,4 ]
Hien, Tran Tinh [2 ]
Farrar, Jeremy J. [1 ,4 ]
机构
[1] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam
[2] Hosp Trop Dis, Ho Chi Minh City, Vietnam
[3] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand
[4] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England
来源
PLOS ONE | 2008年 / 3卷 / 03期
基金
英国惠康基金;
关键词
D O I
10.1371/journal.pone.0001772
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Methods: The aim of this prospective, observational cohort study was to determine the clinical and microbiological features, outcome, and baseline variables predictive of death, in Vietnamese adults with HIV-associated tuberculous meningitis (TBM). 58 patients were admitted to the Hospital for Tropical Diseases in Ho Chi Minh City and underwent routine clinical and laboratory assessments. Treatment was with standard antituberculous therapy and adjunctive dexamethasone; antiretroviral therapy was not routinely available. Patients were followed up until the end of TB treatment or death. Results: The median symptom duration was 11 days (range 2-90 days), 21.8% had a past history of TB, and 41.4% had severe (grade 3) TBM. The median CD4 count was 32 cells/mm(3). CSF findings were as follows: median leucocyte count 438610 9 cells/l (63% neutrophils), 69% smear positive and 87.9% culture positive. TB drug resistance rates were high (13% mono-resistance 32.6% poly-resistance 8.7% multidrug resistance). 17% patients developed further AIDS-defining illnesses. 67.2% died (median time to death 20 days). Three baseline variables were predictive of death by multivariate analysis: increased TBM grade [adjusted hazard ratio (AHR) 1.73, 95% CI 1.08-2.76, p = 0.02], lower serum sodium (AHR 0.93, 95% CI 0.89 to 0.98, p = 0.002) and decreased CSF lymphocyte percentage (AHR 0.98, 95% CI 0.97 to 0.99, p = 0.003). Conclusions: HIV-associated TBM is devastating disease with a dismal prognosis. CSF findings included CSF neutrophil predominance, high rates of smear and culture positivity, and high rates of antituberculous drug resistance. Three baseline variables were independently associated with death: increased TBM grade; low serum sodium and decreased CSF lymphocyte percentage.
引用
收藏
页数:7
相关论文
共 42 条
[1]  
[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603
[2]  
[Anonymous], 2006, GLOBAL TUBERCULOSIS
[3]   Tuberculous meningitis:: A comparative study in relation to concurrent human immunodeficiency virus infection [J].
Azuaje, Carlos ;
Fernandez Hidalgo, Nuria ;
Almirante, Benito ;
Martin Casabona, Nuria ;
Ribera, Esteve ;
Diaz, Marjorie ;
Prats, Guillem ;
Pahissa, Albert .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (04) :245-250
[4]   TUBERCULOUS MENINGITIS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BERENGUER, J ;
MORENO, S ;
LAGUNA, F ;
VICENTE, T ;
ADRADOS, M ;
ORTEGA, A ;
GONZALEZLAHOZ, J ;
BOUZA, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :668-672
[5]   The incidence of false-positive cultures for Mycobacterium tuberculosis [J].
Burman, WJ ;
Stone, BL ;
Reves, RR ;
Wilson, ML ;
Yang, ZH ;
ElHajj, H ;
Bates, JH ;
Cave, MD .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) :321-326
[6]  
CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565
[7]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[8]   Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy [J].
Dean, GL ;
Edwards, SG ;
Ives, NJ ;
Matthews, G ;
Fox, EF ;
Navaratne, L ;
Fisher, M ;
Taylor, GP ;
Miller, R ;
Taylor, CB ;
de Ruiter, A ;
Pozniak, AL .
AIDS, 2002, 16 (01) :75-83
[9]   Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy [J].
Dheda, K ;
Lampe, FC ;
Johnson, MA ;
Lipman, MC .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) :1670-1676
[10]   TUBERCULOUS MENINGITIS IN PATIENTS WITH AND WITHOUT HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
DUBE, MP ;
HOLTOM, PD ;
LARSEN, RA .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (05) :520-524